Angiotensin IV Attenuates Diabetic Cardiomyopathy Suppressing FoxO1-induced Excessive Autophagy, Apoptosis and Fibrosis

Overview

Journal Theranostics

Date 2021 Sep 15

PMID 34522203

Citations 49

Authors

Meng Zhang

Wenhai Sui

Yanqiu Xing

Jing Cheng

Cheng Cheng

Fei Xue

Jie Zhang

Xiaohong Wang

Cheng Zhang

Panpan Hao

Yun Zhang

Affiliations

Soon will be listed here.

Abstract

The rennin-angiotensin-aldosterone system (RAAS) plays a critical role in the pathogenesis of diabetic cardiomyopathy, but the role of a member of RAAS, angiotensin IV (Ang IV), in this disease and its underlying mechanism are unclear. This study was aimed to clarify the effects of Ang IV and its downstream mediator forkhead box protein O1 (FoxO1) on diabetic cardiomyopathy. , diabetic mice were treated with low-, medium- and high-dose Ang IV, ATR antagonist divalinal, FoxO1 inhibitor AS1842856 (AS), or their combinations. , H9C2 cardiomyocytes and cardiac fibroblasts were treated with different concentrations of glucose, low-, medium- and high-dose Ang IV, divalinal, FoxO1-overexpression plasmid (FoxO1-OE), AS, or their combinations. Ang IV treatment dose-dependently attenuated left ventricular dysfunction, fibrosis, and myocyte apoptosis in diabetic mice. Besides, enhanced autophagy and FoxO1 protein expression by diabetes were dose-dependently suppressed by Ang IV treatment. However, these cardioprotective effects of Ang IV were completely abolished by divalinal administration. Bioinformatics analysis revealed that the differentially expressed genes were enriched in autophagy, apoptosis, and FoxO signaling pathways among control, diabetes, and diabetes+high-dose Ang IV groups. Similar to Ang IV, AS treatment ameliorated diabetic cardiomyopathy in mice. , high glucose stimulation increased collagen expression, apoptosis, overactive autophagy flux and FoxO1 nuclear translocation in cardiomyocytes, and upregulated collagen and FoxO1 expression in cardiac fibroblasts, which were substantially attenuated by Ang IV treatment. However, these protective effects of Ang IV were completely blocked by the use of divalinal or FoxO1-OE, and these detrimental effects were reversed by the additional administration of AS. Ang IV treatment dose-dependently attenuated left ventricular dysfunction and remodeling in a mouse model of diabetic cardiomyopathy, and the mechanisms involved stimulation of ATR and suppression of FoxO1-mediated fibrosis, apoptosis, and overactive autophagy.

Citing Articles

FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription.

Xie Y, Yan F, Liu X, Yu L, Yan H, Shang Z Drug Des Devel Ther. 2025; 19:1543-1560.

PMID: 40061815 PMC: 11890352. DOI: 10.2147/DDDT.S492576.

Autophagy in High-Fat Diet and Streptozotocin-Induced Metabolic Cardiomyopathy: Mechanisms and Therapeutic Implications.

Zhou R, Zhang Z, Li X, Duan Q, Miao Y, Zhang T Int J Mol Sci. 2025; 26(4).

PMID: 40004130 PMC: 11855906. DOI: 10.3390/ijms26041668.

Peritoneal protein clearance, fluid overload, and cardiovascular events in patients undergoing peritoneal dialysis: a prospective cohort study.

Ye H, Liu R, Cao P, Guo Q, Chen W, Mao H Ren Fail. 2025; 47(1):2461676.

PMID: 39962729 PMC: 11837914. DOI: 10.1080/0886022X.2025.2461676.

Knockdown gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation.

Xu A, Shen Z, Wang S, Luan H, Xu Y, Kang Z Front Pharmacol. 2025; 15:1496380.

PMID: 39931517 PMC: 11808915. DOI: 10.3389/fphar.2024.1496380.

GPX4 expression changes in proximal tubule cells highlight the role of ferroptosis in IgAN.

Qing J, Zhang L, Fan R, Zhi H, Li C, Li Y Sci Rep. 2025; 15(1):3886.

PMID: 39890853 PMC: 11785777. DOI: 10.1038/s41598-025-87228-9.

References

Yao Q, Ke Z, Guo S, Yang X, Zhang F, Liu X . Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis. J Mol Cell Cardiol. 2018; 124:26-34. DOI: 10.1016/j.yjmcc.2018.10.004. View

Weng J, Zhou Z, Guo L, Zhu D, Ji L, Luo X . Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ. 2018; 360:j5295. PMC: 5750780. DOI: 10.1136/bmj.j5295. View

Li X, Wu Y, Zhao J, Wang H, Tan J, Yang M . Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus. Theranostics. 2020; 10(6):2675-2695. PMC: 7052888. DOI: 10.7150/thno.40735. View

Yang J, Dong M, Meng X, Zhao Y, Yang X, Liu X . Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol. 2013; 33(8):1978-85. DOI: 10.1161/ATVBAHA.113.301320. View

Yang H, Zeng X, Wang H, Zhang L, Dong X, Guo S . Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor. Peptides. 2011; 32(10):2108-15. DOI: 10.1016/j.peptides.2011.09.015. View

Mialet-Perez J, Vindis C . Autophagy in health and disease: focus on the cardiovascular system. Essays Biochem. 2017; 61(6):721-732. DOI: 10.1042/EBC20170022. View

Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S . Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol. 2010; 12(7):665-75. DOI: 10.1038/ncb2069. View

Chansel D, Czekalski S, Vandermeersch S, Ruffet E, Fournie-Zaluski M, Ardaillou R . Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells. Am J Physiol. 1998; 275(4):F535-42. DOI: 10.1152/ajprenal.1998.275.4.F535. View

Mei Y, Thompson M, Cohen R, Tong X . Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta. 2014; 1852(2):243-51. PMC: 4231019. DOI: 10.1016/j.bbadis.2014.05.005. View

10.

Iwai-Kanai E, Yuan H, Huang C, Sayen M, Perry-Garza C, Kim L . A method to measure cardiac autophagic flux in vivo. Autophagy. 2008; 4(3):322-9. PMC: 3709927. DOI: 10.4161/auto.5603. View

11.

Zhao Y, Yin H, Yu Q, Qiao Y, Dai H, Zhang M . ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Hum Gene Ther. 2010; 21(11):1545-54. DOI: 10.1089/hum.2009.160. View

12.

He C, Zhu H, Li H, Zou M, Xie Z . Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes. 2012; 62(4):1270-81. PMC: 3609561. DOI: 10.2337/db12-0533. View

13.

Kong J, Zhang K, Meng X, Zhang Y, Zhang C . Dose-Dependent Bidirectional Effect of Angiotensin IV on Abdominal Aortic Aneurysm via Variable Angiotensin Receptor Stimulation. Hypertension. 2015; 66(3):617-26. DOI: 10.1161/HYPERTENSIONAHA.115.05482. View

14.

Nakamura M, Sadoshima J . Cardiomyopathy in obesity, insulin resistance and diabetes. J Physiol. 2019; 598(14):2977-2993. DOI: 10.1113/JP276747. View

15.

Yan D, Cai Y, Luo J, Liu J, Li X, Ying F . FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes. J Cell Mol Med. 2020; 24(14):7850-7861. PMC: 7348139. DOI: 10.1111/jcmm.15418. View

16.

Jia G, Whaley-Connell A, Sowers J . Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2017; 61(1):21-28. PMC: 5720913. DOI: 10.1007/s00125-017-4390-4. View

17.

Auguste G, Gurha P, Lombardi R, Coarfa C, Willerson J, Marian A . Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies. Circ Res. 2018; 122(5):678-692. PMC: 5834384. DOI: 10.1161/CIRCRESAHA.117.312052. View

18.

Ren J, Taegtmeyer H . Too much or not enough of a good thing--The Janus faces of autophagy in cardiac fuel and protein homeostasis. J Mol Cell Cardiol. 2015; 84:223-6. DOI: 10.1016/j.yjmcc.2015.03.001. View

19.

Hao P, Yang J, Liu Y, Zhang M, Zhang K, Gao F . Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy. Sci Rep. 2015; 5:8794. PMC: 4350094. DOI: 10.1038/srep08794. View

20.

Hao P, Yang J, Zhang M, Zhang K, Chen Y, Zhang C . Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2015; 308(9):H1007-19. DOI: 10.1152/ajpheart.00563.2014. View